(Q58903565)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

postmenopausal osteoporosis

16 December 2019

main subject

osteoporosis

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Maurizio Rossini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

V Braga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

F Colapietro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

E Battaglia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

D Righetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

R Prizzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

S Adami

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

342-345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

The acute-phase response after bisphosphonate administration

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Adverse effects of bisphosphonates. A comparative review

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Aminohexane diphosphonate in the treatment of Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Intravenous neridronate in adults with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Vertebral fracture assessment using a semiquantitative technique.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900084-X

7 January 2021

10.1016/S8756-3282(03)00084-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678775%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference